This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2017 May 30;8(22):35482-35483.

doi: 10.18632/onco_target.16613.

ROS and radiotherapy: more we care

Pierre Sonveaux¹

Affiliations

PMID: 28415657
PMCID: PMC5482588
DOI: 10.18632/onco_target.16613

ROS and radiotherapy: more we care

Pierre Sonveaux. Onco_target. 2017.

. 2017 May 30;8(22):35482-35483.

doi: 10.18632/onco_target.16613.

Author

Pierre Sonveaux¹

Affiliation

¹ Pole of Pharmacology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.

PMID: 28415657
PMCID: PMC5482588
DOI: 10.18632/onco_target.16613

No abstract available

Keywords: auranofin; radiotherapy; reactive oxygen species; thioredoxin; tumor metabolism.

PubMed Disclaimer

Similar articles

Auranofin radiosensitizes tumor cells through _targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
Wang H, Bouzakoura S, de Mey S, Jiang H, Law K, Dufait I, Corbet C, Verovski V, Gevaert T, Feron O, Van den Berge D, Storme G, De Ridder M. Wang H, et al. Onco_target. 2017 May 30;8(22):35728-35742. doi: 10.18632/onco_target.16113. Onco_target. 2017. PMID: 28415723 Free PMC article.
Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
Hwang-Bo H, Jeong JW, Han MH, Park C, Hong SH, Kim GY, Moon SK, Cheong J, Kim WJ, Yoo YH, Choi YH. Hwang-Bo H, et al. Gen Physiol Biophys. 2017 Apr;36(2):117-128. doi: 10.4149/gpb_2016043. Epub 2017 Feb 20. Gen Physiol Biophys. 2017. PMID: 28218611
Methionine restriction exposes a _targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase.
Malin D, Lee Y, Chepikova O, Strekalova E, Carlson A, Cryns VL. Malin D, et al. Breast Cancer Res Treat. 2021 Dec;190(3):373-387. doi: 10.1007/s10549-021-06398-y. Epub 2021 Sep 22. Breast Cancer Res Treat. 2021. PMID: 34553295 Free PMC article.
Potential Anticancer Activity of Auranofin.
Onodera T, Momose I, Kawada M. Onodera T, et al. Chem Pharm Bull (Tokyo). 2019;67(3):186-191. doi: 10.1248/cpb.c18-00767. Chem Pharm Bull (Tokyo). 2019. PMID: 30827998 Review.
The gold complex auranofin: new perspectives for cancer therapy.
Abdalbari FH, Telleria CM. Abdalbari FH, et al. Discov Oncol. 2021 Oct 20;12(1):42. doi: 10.1007/s12672-021-00439-0. Discov Oncol. 2021. PMID: 35201489 Free PMC article. Review.

See all similar articles

Cited by

_targeted Treatment of Head and Neck (Pre)Cancer: Preclinical _target Identification and Development of Novel Therapeutic Applications.
van Harten AM, Brakenhoff RH. van Harten AM, et al. Cancers (Basel). 2021 Jun 3;13(11):2774. doi: 10.3390/cancers13112774. Cancers (Basel). 2021. PMID: 34204886 Free PMC article. Review.
Radiation therapy-induced reactive oxygen species specifically eliminates CD19⁺IgA⁺ B cells in nasopharyngeal carcinoma.
Li W, Wang L, Shen C, Xu T, Chu Y, Hu C. Li W, et al. Cancer Manag Res. 2019 Jul 8;11:6299-6309. doi: 10.2147/CMAR.S202375. eCollection 2019. Cancer Manag Res. 2019. PMID: 31372036 Free PMC article.
SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.
Yadav S, Kowolik CM, Lin M, Zuro D, Hui SK, Riggs AD, Horne DA. Yadav S, et al. Mol Carcinog. 2019 Jan;58(1):113-125. doi: 10.1002/mc.22913. Epub 2018 Oct 5. Mol Carcinog. 2019. PMID: 30242889 Free PMC article.
The potential of gas plasma technology for _targeting breast cancer.
Bekeschus S, Saadati F, Emmert S. Bekeschus S, et al. Clin Transl Med. 2022 Aug;12(8):e1022. doi: 10.1002/ctm2.1022. Clin Transl Med. 2022. PMID: 35994412 Free PMC article. Review.
Modeling neoplastic disease with spheroids and organoids.
Zanoni M, Cortesi M, Zamagni A, Arienti C, Pignatta S, Tesei A. Zanoni M, et al. J Hematol Oncol. 2020 Jul 16;13(1):97. doi: 10.1186/s13045-020-00931-0. J Hematol Oncol. 2020. PMID: 32677979 Free PMC article. Review.

See all "Cited by" articles

References

1. Spugnini EP, et al. Biochim Biophys Acta. 2015;1848:2715–2726. - PubMed
1. Allen E, et al. Cell Rep. 2016;15:1144–1160. - PMC - PubMed
1. Gray LH, et al. Br J Radiol. 1953;26:638–648. - PubMed
1. Danhier P, et al. Semin Radiat Oncol. 2013;23:262–272. - PubMed
1. Onco_target. 2017 Mar 10; doi: 10.18632/onco_target.16113. [Epub ahead of print] - DOI

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

NODES